The healthcare and life sciences industries are undergoing transformative growth, fueled by innovation in pharmaceuticals, biotechnology, medical devices, and digital health solutions. For companies, investors, and executives operating in this dynamic ecosystem, actionable market intelligence is essential. Healthcare market research firms provide critical insights into therapeutic areas, competitive landscapes, regulatory frameworks, market trends, and emerging opportunities. Understanding the strengths and services of top-tier market research companies enables stakeholders to make informed strategic decisions, optimize investments, and drive innovation.
The following article highlights the top 10 healthcare market research companies globally, ranked based on their expertise, global reach, technological capability, and influence within the healthcare sector.
IQVIA stands as a global leader in healthcare analytics, real-world evidence, and market intelligence. The firm combines advanced data science with one of the world’s largest healthcare data ecosystems, enabling pharmaceutical and biotech companies to track disease trends, monitor treatment patterns, and benchmark competitive activities across multiple therapeutic areas.
Key Offerings: IQVIA’s portfolio includes epidemiological modeling, patient segmentation, clinical trial analytics, product lifecycle management, and forecasting. Their real-world data derived from electronic health records (EHRs), claims databases, and patient registries allows for predictive insights that guide portfolio strategy and commercial execution.
Why IQVIA Leads: The company’s ability to integrate real-world data with predictive analytics provides a clear advantage for organizations seeking precision medicine strategies, value-based care models, and market entry guidance. Its global presence across 100+ countries ensures comprehensive geographic coverage and robust sampling.
Ideal For: Large pharmaceutical, biotech, and medtech companies looking for high-quality, evidence-based market intelligence and data-driven strategies.
GlobalData Healthcare is recognized for its in-depth therapeutic insights and proprietary intelligence platforms. The firm serves a wide range of healthcare stakeholders, including pharma, biotech, medtech, and investors, offering strategic foresight into both mature and emerging markets.
Key Offerings: GlobalData provides competitive intelligence, pipeline analysis, epidemiological forecasting, company profiling, and regulatory monitoring. Their cardiovascular, oncology, and rare disease research is widely respected for its accuracy and comprehensiveness.
Why GlobalData Healthcare Excels: The company combines expert analyst insights with quantitative modeling, enabling clients to anticipate market shifts, assess emerging technologies, and optimize investment decisions. Its focus on therapeutic depth and global market coverage allows clients to explore collaboration opportunities and expansion strategies confidently.
Ideal For: Healthcare executives, R&D leaders, and investors who require precise, actionable insights into specific therapeutic areas and market trends.
Frost & Sullivan has built a long-standing reputation in healthcare market research and consulting. The firm emphasizes growth strategy, technology assessment, and competitive benchmarking, providing actionable intelligence for executives and investors alike.
Key Offerings: Frost & Sullivan’s services include market sizing, growth opportunity analysis, regulatory and reimbursement evaluation, and technology adoption studies. Their expertise spans pharmaceuticals, medical devices, diagnostics, and digital health technologies.
Why Frost & Sullivan Stands Out: With over six decades of consulting experience, Frost & Sullivan combines strategic foresight with practical guidance for market entry, portfolio management, and commercial planning. Their focus on innovation ecosystems allows clients to identify disruptive technologies and optimize R&D investments.
Ideal For: Companies seeking guidance on technology adoption, market trends, and strategic growth opportunities across diverse healthcare sectors.
DelveInsight is a specialized healthcare market research and consulting firm recognized for its deep therapeutic expertise and customized intelligence solutions. The company provides detailed insights into disease epidemiology, treatment landscapes, drug pipelines, and market forecasts across multiple therapeutic areas.
Key Offerings: DelveInsight’s portfolio includes over 7,000 indications and 27,000 pipeline drugs, offering pharmaceutical and biotech companies comprehensive analyses of market dynamics and unmet medical needs. Their services also encompass competitive intelligence, market entry assessments, licensing opportunities, and commercialization strategy support.
Why DelveInsight Excels: DelveInsight’s strength lies in its ability to deliver actionable, therapeutic-specific intelligence tailored to client objectives. The company’s epidemiological modeling combined with in-depth stakeholder analysis enables organizations to make data-driven R&D and commercial decisions.
Ideal For: Biopharma companies, investors, and consulting groups seeking precise, disease-specific market insights and guidance for portfolio development, geographic expansion, and strategic partnerships.
MarketsandMarkets has emerged as one of the fastest-growing global market research and consulting firms, offering extensive coverage of high-growth niches in healthcare and life sciences.
Key Offerings: The firm provides competitive intelligence, market sizing, technology analysis, and growth forecasts across pharmaceuticals, diagnostics, healthcare IT, and digital health. Their proprietary KnowledgeStore platform allows clients to identify emerging trends, potential revenue streams, and cross-market opportunities.
Why MarketsandMarkets Leads: Their combination of AI-driven insights and expert human analysis enables rapid identification of market trends and investment opportunities. MarketsandMarkets also contributes to thought leadership by facilitating industry conferences and innovation collaborations.
Ideal For: Fortune 500 companies, healthcare investors, and innovators seeking comprehensive market intelligence and growth strategy support.
Grand View Research is renowned for its rigorous market intelligence, data modeling, and forecasting capabilities. The firm’s healthcare research covers pharmaceuticals, medical devices, biotechnology, and digital health segments.
Key Offerings: Their cardiovascular, oncology, and rare disease research provides detailed analysis of product innovation, regulatory changes, competitive landscape, and market potential. Grand View Research combines qualitative and quantitative methodologies to deliver actionable insights for decision-makers.
Why Grand View Research Excels: The company’s ability to integrate operational, clinical, and financial data enables a holistic understanding of markets, supporting portfolio strategy, investment planning, and market entry evaluations.
Ideal For: Healthcare executives, investors, and R&D leaders requiring robust, long-term market forecasts and strategic recommendations.
Kantar Health, now operating as part of Cerner Enviza, specializes in patient-centric market research and real-world evidence. The firm bridges clinical outcomes with behavioral and market insights, delivering actionable intelligence for pharma and biotech companies.
Key Offerings: Services include longitudinal patient tracking, ethnographic research, KOL engagement, brand performance analysis, and health outcome studies. Kantar’s proprietary data panels and advanced modeling enhance decision-making and commercialization strategy.
Why Kantar Health Excels: Their focus on patient behavior, clinical validation, and longitudinal tracking provides a comprehensive understanding of therapy adoption, treatment pathways, and unmet needs. This combination enables clients to optimize go-to-market strategies effectively.
Ideal For: Pharma companies seeking to align clinical insights with patient-centric commercial strategies.
The Business Research Company (TBRC)
TBRC provides global healthcare market intelligence with a focus on actionable insights for strategic decision-making. The firm offers comprehensive research spanning pharmaceuticals, medical devices, and biotechnology.
Key Offerings: TBRC’s services include market sizing, competitive benchmarking, epidemiological analysis, and investment analytics. Their datasets cover therapeutic classes, regional segmentation, and healthcare expenditure trends.
Why TBRC Excels: The company’s global network of analysts ensures region-specific insights, particularly valuable for companies expanding into emerging markets. TBRC combines methodological rigor with actionable recommendations, supporting product launches, partnerships, and investment decisions.
Ideal For: Investors, healthcare executives, and consulting firms requiring data-driven intelligence for global market planning.
BioInformatics Inc. (Science and Medicine Group)
BioInformatics Inc. specializes in life sciences market intelligence, focusing on diagnostics, clinical research tools, and scientific instrumentation. The firm leverages primary research, proprietary panels, and behavioral insights to deliver accurate market assessments.
Key Offerings: Services include customer behavior studies, market segmentation, technology adoption tracking, and purchasing trend analysis. Their Science Advisory Board community ensures research validity and relevance.
Why BioInformatics Excels: The combination of primary research, expert validation, and advanced analytics allows clients to fine-tune marketing strategies and identify unmet market needs. Their research is particularly relevant for diagnostics and laboratory instrumentation sectors.
Ideal For: Companies developing diagnostic tools, clinical research instruments, or laboratory technologies seeking actionable intelligence.
The global healthcare market is rapidly evolving, driven by technological innovation, regulatory changes, and a growing focus on patient-centric care. Market research firms serve as strategic partners, enabling pharma, biotech, medtech, and investors to navigate these complexities with confidence.
The top 10 global leaders—IQVIA, GlobalData Healthcare, Frost & Sullivan, DelveInsight, MarketsandMarkets, Grand View Research, Kantar Health, TBRC, BioInformatics Inc., and MarketsandMarkets—offer unique expertise, robust datasets, and actionable intelligence. Partnering with these firms ensures that healthcare stakeholders remain informed, strategic, and prepared to capitalize on emerging opportunities in a competitive and fast-moving industry.